Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto R Frey

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|August 21, 2021
Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational studyHendrik Booke, Otto R Frey, Anka C Röhr, et al.
Pharmaceutics|May 28, 2022
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic StudyDzenefa Alihodzic, Sebastian G Wicha, Otto R Frey, et al.
Therapeutic Drug Monitoring|January 25, 2020
What Are the Predictors for Achieving Therapeutic Levetiracetam Serum Concentrations in Adult Neurological Patients?Menino O Cotta, Mohd H Abdul-Aziz, Otto R Frey, et al.
International Journal of Antimicrobial Agents|July 17, 2017
Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot studySebastian G Wicha, Otto R Frey, Anka C Roehr, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|June 28, 2021
Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolidRawan Alraish, Sebastian G Wicha, Otto R Frey, et al.
Critical Care (London, England)|October 26, 2016
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational studyUte Blassmann, Anka C Roehr, Otto R Frey, et al.
Medicine|June 4, 2021
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainmentUte Chiriac, Otto R Frey, Anka C Roehr, et al.
Annals of Intensive Care|August 6, 2020
Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)Rawan Alraish, Sebastian G Wicha, Otto R Frey, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2019
CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational studyUte Blassmann, William Hope, Anka C Roehr, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill PatientsUte Chiriac, Daniel Richter, Otto R Frey, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|August 21, 2021
Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational studyHendrik Booke, Otto R Frey, Anka C Röhr, et al.
Pharmaceutics|May 28, 2022
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic StudyDzenefa Alihodzic, Sebastian G Wicha, Otto R Frey, et al.
Therapeutic Drug Monitoring|January 25, 2020
What Are the Predictors for Achieving Therapeutic Levetiracetam Serum Concentrations in Adult Neurological Patients?Menino O Cotta, Mohd H Abdul-Aziz, Otto R Frey, et al.
International Journal of Antimicrobial Agents|July 17, 2017
Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot studySebastian G Wicha, Otto R Frey, Anka C Roehr, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|June 28, 2021
Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolidRawan Alraish, Sebastian G Wicha, Otto R Frey, et al.
Critical Care (London, England)|October 26, 2016
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational studyUte Blassmann, Anka C Roehr, Otto R Frey, et al.
Medicine|June 4, 2021
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainmentUte Chiriac, Otto R Frey, Anka C Roehr, et al.
Annals of Intensive Care|August 6, 2020
Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)Rawan Alraish, Sebastian G Wicha, Otto R Frey, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2019
CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational studyUte Blassmann, William Hope, Anka C Roehr, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill PatientsUte Chiriac, Daniel Richter, Otto R Frey, et al.
Pageof 4